Xavier Champavere
Chief Executive Officer at Arvem SAS
Profile
Xavier Champavere has held positions as a Non-Executive Director at Moleac Pte Ltd.
and as a Co-Managing Director at Arvem SAS.
Xavier Champavere active positions
| Companies | Position | Start |
|---|---|---|
Arvem SAS
 Arvem SAS Advertising/Marketing ServicesCommercial Services Arvem SAS operates as an advertising agency. The company was founded on November 23, 1999 and is headquartered in Paris, France. | Chief Executive Officer | 15/07/2011 |
Moleac Pte Ltd.
 Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Arvem SAS
Arvem SAS Advertising/Marketing ServicesCommercial Services Arvem SAS operates as an advertising agency. The company was founded on November 23, 1999 and is headquartered in Paris, France. | Commercial Services |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- Xavier Champavere
